Pulmonary sclerosing pneumocytoma and mortality risk

BACKGROUND: Surgical resection is usually recommended for the treatment of pulmonary sclerosing pneumocytoma (PSP). However, no comparative study has demonstrated that surgical resection leads to improved outcomes. We aimed to compare all-cause mortality between patients with PSP who underwent surge...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, So Jeong, Kang, Hye-Rin, Lee, Choon Geun, Choi, Seung Ho, Kim, Yeon Wook, Lee, Hyun Woo, Lee, Chang-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641959/
https://www.ncbi.nlm.nih.gov/pubmed/36344955
http://dx.doi.org/10.1186/s12890-022-02199-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641959/
https://www.ncbi.nlm.nih.gov/pubmed/36344955
http://dx.doi.org/10.1186/s12890-022-02199-1

Ejemplares similares